![](/img/cover-not-exists.png)
Evidence of Clinical Activity for Cetuximab Combined with Irinotecan in a Patient with Refractory Anal Canal Squamous-Cell Carcinoma: Report of a Case
Lan K. Phan, Paulo M. HoffVolume:
50
Language:
english
Pages:
4
DOI:
10.1007/s10350-006-0786-9
Date:
March, 2007
File:
PDF, 219 KB
english, 2007